Cargando…

Effective natural inhibitors targeting granzyme B in rheumatoid arthritis by computational study

BACKGROUND: Rheumatoid arthritis (RA) is an autoimmune disease characterized by erosive arthritis, and current treatments for RA fall short of the outcomes expected by clinicians and patients. OBJECTIVES: This study aimed to identify novel therapeutic and prognostic targets in RA at the genomic leve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xinyu, Jiang, Ye, Zhou, Pengcheng, Lin, Liangxin, Yang, Yilin, Yang, Qifan, Zhang, Jiting, Zhu, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792495/ https://www.ncbi.nlm.nih.gov/pubmed/36582296 http://dx.doi.org/10.3389/fmed.2022.1052792

Ejemplares similares

Effective natural inhibitors targeting IGF-1R by computational study
por: Wang, Xinyu, et al.
Publicado: (2022)

Impairment of Granzyme B-Producing Regulatory B Cells Correlates with Exacerbated Rheumatoid Arthritis
por: Xu, Liling, et al.
Publicado: (2017)

Role of the granzyme family in rheumatoid arthritis: Current Insights and future perspectives
por: Zheng, Yixin, et al.
Publicado: (2023)

JAK Inhibitors and Modulation of B Cell Immune Responses in Rheumatoid Arthritis
por: Moura, Rita A., et al.
Publicado: (2021)

Elevated serum granzyme B levels are associated with disease activity and joint damage in patients with rheumatoid arthritis
por: Qiao, Junjie, et al.
Publicado: (2020)

Editorial: Rheumatoid arthritis: Pathogenesis and target-treatments
por: Piantoni, Silvia, et al.
Publicado: (2023)

Editorial: Risk factors for Rheumatoid Arthritis and pre-Rheumatoid Arthritis
por: Sapart, Emillie, et al.
Publicado: (2022)

Apoptotic pathways are selectively activated by granzyme A and/or granzyme B in CTL-mediated target cell lysis
por: Pardo, Julián, et al.
Publicado: (2004)

Highlights of Strategies Targeting Fibroblasts for Novel Therapies for Rheumatoid Arthritis
por: Chu, Cong-Qiu
Publicado: (2022)

Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
por: Hernández-Breijo, Borja, et al.
Publicado: (2021)

The mammalian target of rapamycin contributes to synovial fibroblast pathogenicity in rheumatoid arthritis
por: Barker, Brianne E., et al.
Publicado: (2023)

Human Granzyme B Based Targeted Cytolytic Fusion Proteins
por: Hlongwane, Precious, et al.
Publicado: (2018)

Granzyme B Attenuates Bacterial Virulence by Targeting Secreted Factors
por: León, Diego López, et al.
Publicado: (2020)

In silico prediction of the granzyme B degradome
por: Wee, Lawrence JK, et al.
Publicado: (2011)

Granzyme B in Autoimmune Skin Disease
por: Gleave, Anna, et al.
Publicado: (2023)

Initiation of Apoptosis by Granzyme B Requires Direct Cleavage of Bid, but Not Direct Granzyme B–Mediated Caspase Activation
por: Sutton, Vivien R., et al.
Publicado: (2000)

The Clinical Value of Autoantibodies in Rheumatoid Arthritis
por: Bugatti, Serena, et al.
Publicado: (2018)

Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
por: Llorente, Irene, et al.
Publicado: (2020)

Insights Into the Concept of Rheumatoid Arthritis Flare
por: Bozzalla-Cassione, Emanuele, et al.
Publicado: (2022)

Pathomechanisms of bone loss in rheumatoid arthritis
por: Sakthiswary, Rajalingham, et al.
Publicado: (2022)

Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo
por: Haile, Yohannes, et al.
Publicado: (2015)

Presence of Protease Inhibitor 9 and Granzyme B in Healthy and Pathological Human Corneas
por: Reinstein Merjava, Stanislava, et al.
Publicado: (2022)

Altered Distribution of Circulating T Follicular Helper-Like Cell Subsets in Rheumatoid Arthritis Patients
por: Su, Rui, et al.
Publicado: (2021)

The Role of Vitamin D in Combination Treatment for Patients With Rheumatoid Arthritis
por: Wu, Jianhong, et al.
Publicado: (2020)

Yoga for Treating Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
por: Ye, Xiangling, et al.
Publicado: (2020)

Noninvasive quantification of granzyme B in cardiac allograft rejection using targeted ultrasound imaging
por: Jin, Yunjie, et al.
Publicado: (2023)

Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease
por: Chai, Dandan, et al.
Publicado: (2023)

Elderly-onset rheumatoid arthritis vs. polymyalgia rheumatica: Differences in pathogenesis
por: Wu, Jinzhi, et al.
Publicado: (2023)

Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway
por: Wang, Huixue, et al.
Publicado: (2020)

Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis
por: Aslam, Fawad, et al.
Publicado: (2018)

EGFR-Targeted Granzyme B Expressed in NK Cells Enhances Natural Cytotoxicity and Mediates Specific Killing of Tumor Cells
por: Oberoi, Pranav, et al.
Publicado: (2013)

Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis
por: Cuervo, Andrea, et al.
Publicado: (2021)

Risk Factors for Developing Rheumatoid Arthritis in Patients With Undifferentiated Arthritis and Inflammatory Arthralgia
por: Novella-Navarro, Marta, et al.
Publicado: (2021)

An Analysis of Rheumatoid Arthritis Hospitalizations
por: Kannayiram, Sandhya Shri, et al.
Publicado: (2020)

Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes
por: Goggi, J. L., et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Mediated Cancer Theranostics with Radiolabeled Anti-Granzyme B Peptide
por: de Aguiar Ferreira, Carolina, et al.
Publicado: (2022)

Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
por: Goggi, Julian L., et al.
Publicado: (2021)

Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
por: Nakashita, Tamao, et al.
Publicado: (2014)

Factors Determining Retreatment Time Interval of Rituximab in Korean Patients With Rheumatoid Arthritis
por: Kim, Ji-Won, et al.
Publicado: (2021)

Synovial Tissue Heterogeneity in Rheumatoid Arthritis and Changes With Biologic and Targeted Synthetic Therapies to Inform Stratified Therapy
por: Ouboussad, Lylia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o3d30u6r6j5n9o73oapv4n6nfo